Academic · Private company
First Institute of All Medicines
Track this companyFree. Adds First Institute of All Medicines to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- RCT to Assess the Efficacy of Biophoton Therapy to Treat Type 2 DiabetesNA · NOT_YET_RECRUITING · started Jun 8, 2026ClinicalTrials.gov NCT07124208 · fetched Nov 12, 2026
- Impact of Biophoton Therapy on Chronic Severe Arthritis PainNA · RECRUITING · started Mar 28, 2025ClinicalTrials.gov NCT06915012 · fetched Nov 12, 2026
- The Impact of Biophoton Therapy on Self-Grown Stem CellsNA · COMPLETED · started Feb 10, 2025ClinicalTrials.gov NCT06855459 · fetched Nov 12, 2026
- Impact of a Biophoton Therapy on Patients With Brain DisordersNA · RECRUITING · started Nov 8, 2023ClinicalTrials.gov NCT06147999 · fetched Nov 12, 2026
- Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton GeneratorsNA · COMPLETED · started Oct 31, 2023ClinicalTrials.gov NCT06049849 · fetched Nov 12, 2026
- Impact of Biophoton Generator on Chronic-Stroke Patients' RecoveryNA · COMPLETED · started May 10, 2023ClinicalTrials.gov NCT05898334 · fetched Nov 12, 2026